ArticleJournal of periodontal & implant science2026
circMYO9B affects the progression of periodontitis by targeting the miR-4731-5p/USP15 axis.
Article in Journal of periodontal & implant science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
purposePeriodontitis is a common oral disease characterized by inflammation and destruction of periodontal tissues. Competitive endogenous RNAs (ceRNAs) are known to regulate inflammatory responses. This study aimed to investigate the role of circular RNA MYO9B (circMYO9B), as a potential ceRNA, in the progression of periodontitis and to elucidate its underlying regulatory mechanism.
methodsThis study included 69 healthy controls and 71 patients with periodontitis. Lipopolysaccharide (LPS)-treated periodontal ligament cells (PDLCs) were used as an
resultscircMYO9B expression was significantly elevated in the gingival crevicular fluid of patients with periodontitis and in LPS-treated PDLCs. Receiver operating characteristic curve analysis demonstrated that circMYO9B had diagnostic potential for periodontitis (area under the curve: 0.919). LPS stimulation reduced PDLC viability and migratory capacity while increasing inflammatory cytokine production and apoptosis. circMYO9B directly targeted and negatively regulated miR-4731-5p. Silencing circMYO9B significantly attenuated LPS-induced PDLC dysfunction, whereas inhibition of miR-4731-5p abolished the protective effects of circMYO9B knockdown. USP15 was identified as a direct downstream target of miR-4731-5p: overexpression of miR-4731-5p alleviated LPS-induced cellular injury in PDLCs, but this protective effect was markedly reversed by concomitant USP15 overexpression.
conclusionscircMYO9B is associated with periodontitis progression through the miR-4731-5p/USP15 regulatory axis, suggesting its potential utility as a therapeutic target in periodontitis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.